Adage Capital Partners’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$75.4M Buy
816,095
+351,190
+76% +$35.3M 0.12% 174
2025
Q4
$47.5M Buy
464,905
+312,783
+206% +$28M 0.07% 266
2025
Q3
$9.5M Sell
152,122
-155,183
-50% -$8.44M 0.02% 642
2025
Q2
$16M Sell
307,305
-539,444
-64% -$24.1M 0.03% 499
2025
Q1
$36.1M Buy
846,749
+566,949
+203% +$24.5M 0.07% 295
2024
Q4
$8.55M Buy
279,800
+223,000
+393% +$6.27M 0.01% 645
2024
Q3
$1.3M Sell
56,800
-243,000
-81% -$6.88M ﹤0.01% 796
2024
Q2
$8.66M Sell
299,800
-17,000
-5% -$396K 0.02% 633
2024
Q1
$6.54M Buy
+316,800
New +$6.79M 0.01% 667
2023
Q3
Sell
-131,800
Closed -$4.72M 897
2023
Q2
$4.72M Buy
+131,800
New +$3.79M 0.01% 676
2022
Q4
Sell
-400,000
Closed -$21.5M 1001
2022
Q3
$21.5M Hold
400,000
0.05% 385
2022
Q2
$16.1M Buy
+400,000
New +$19.8M 0.04% 521
2021
Q3
Sell
-150,000
Closed -$18.6M 1037
2021
Q2
$18.6M Buy
+150,000
New +$20.2M 0.04% 496
2020
Q4
Sell
-80,000
Closed -$8.94M 844
2020
Q3
$8.94M Buy
+80,000
New +$7.32M 0.02% 548

Other funds holding GH

Adage Capital Partners's GH Position: Q1 2026 in Review

Adage Capital Partners increased its Guardant Health (GH) stake by 76% in Q1 2026, buying an estimated $35.3M and bringing the position to 816,095 shares worth $75.4M. The position accounts for 0.12% of the portfolio, ranked #174.

Adage Capital Partners first reported a position in GH in Q3 2020 and has held it in 14 quarters since. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Adage Capital Partners held 816,095 shares of Guardant Health worth $75.4M as of Q1 2026.
  • Adage Capital Partners bought 351,190 Guardant Health shares in Q1 2026, an estimated $35.3M.
  • Guardant Health made up 0.12% of Adage Capital Partners's portfolio in Q1 2026, its #174 holding.
  • Adage Capital Partners first reported a position in Guardant Health in Q3 2020 and has held it in 14 quarters since.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.